the anti-CCL22 Ab (50 μg/ml) inhibited EMT in ESCC cells induced by coculture with pol-TAMs and pri-TAMs, indicating that CCL22 is the cytokine secreted by TAMs that is responsible for EMT in ESCC cells (Fig. 3C, D). Here, CCL22 is linked to esophageal squamous cell carcinoma.